Where do the MOTS-c and NAD+ literatures overlap?
The short answer
Answered from published research literature only. It describes what that literature examines; it is not a statement about use in people. MOTS-c and NAD+ are investigational research material and are not approved products.
Both sit in mitochondrial biology, but they concern different kinds of molecule and are examined differently. MOTS-c is a peptide examined in metabolic-signalling models; NAD+ is a dinucleotide redox coenzyme characterised through its biosynthetic pathway.2573845940693873
The overlap is the subject area rather than the method: one record reports signalling endpoints in animal and cell models, the other reports biochemical characterisation.2573845340693873
Cited literature
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistanceLee C, et al. · Cell Metabolism · 2015PMID 25738459 ↗
- Characterization of the Nicotinamide Adenine Dinucleotide Biosynthesis Pathway and Regulatory Mechanisms in Streptococcus mutansYu H, et al. · The FASEB Journal · 2025PMID 40693873 ↗
- A mitochondrially encoded hormone ameliorates obesity and insulin resistanceZarse K, Ristow M · Cell Metabolism · 2015PMID 25738453 ↗
Research-literature characterization, provided for research context only. For laboratory research use only. Not for human consumption.